FMS (Fresenius Medical Care AG & Co. KGaA) Penghasilan resik perusahaan

The aggregate financial performance of Fresenius Medical Care (FMS) reflects current dynamics where the indicator remains at 1.10. The business relies on its monopoly influence in dialysis and full vertical integration. However, labor shortages and new medications create risks for margins. Management is currently implementing a network restructuring and cutting costs in loss-making regions to optimize expenditures.

The vertical integration of the dialysis cycle at Fresenius Medical Care (FMS) ensures a stable cash flow. An analysis of the company's actual profit allows for the separation of fundamental income from market volatility. This metric measures the daily net cash balance after deducting all operating and tax liabilities. The trend of this indicator reflects the real efficiency of managing the clinic network and production. The growing trend confirms the high resilience of the asset.